Sharps Technology Secures Private Round Funding on August 25, 2025

According to media reports, Sharps Technology completed a Private round of funding on August 25, 2025. Investors in this round include prominent institutions such as Pantera Capital, ParaFi Capital, Borderless Capital, CoinFund, Arrington Capital, Primitive Ventures, Hypersphere Ventures, FalconX, RockawayX, and Quantstamp.Sharps Technology (NASDAQ: STSS) is a medical device company specializing in the research, development, and manufacturing of innovative safety syringes. The company's core mission is to leverage its technology to reduce the risk of disease transmission from needlestick injuries, safeguarding healthcare professionals, patients, and the general public, while enhancing the accuracy and efficiency of drug delivery. Notably, the company has announced the establishment of a SOL digital asset reserve, marking a strategic expansion from traditional medical devices into the digital asset sector.According to the fundraising timeline, Sharps Technology completed over $400 million in PIPE private placement financing alongside the Private round to create the SOL reserve. Subsequently, on August 29, 2025, the company expanded its fundraising target to $1 billion and officially launched its digital asset reserve strategy. As of September 2, 2025, Sharps Technology's holdings of SOL exceeded 2 million tokens. This series of initiatives demonstrates the proactive embrace of digital asset innovation by traditional medical device manufacturers and sets a new benchmark for cross-industry integration. The participation of leading crypto investment firms such as Pantera Capital and ParaFi Capital underscores strong market confidence in the company's digital transformation strategy.